Ani Pharmaceuticals (ANIP) Convertible Debt (2010 - 2019)
Ani Pharmaceuticals (ANIP) posted Convertible Debt of $117.6 million for Q3 2019, up 1.49% sequentially from $115.9 million in Q2 2019, and down 12.33% YoY from $134.1 million in Q3 2018.
Ani Pharmaceuticals (ANIP) Convertible Debt (2010 - 2019) Analysis & Trends
Ani Pharmaceuticals has reported Convertible Debt for 9 years, with the latest figure at $117.6 million in Q3 2019.
- Quarterly Convertible Debt fell 12.33% year-over-year to $117.6 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $117.6 million (down 12.33% YoY) and the FY2018 annual result came in at $112.5 million, down 12.28% from the prior year.
- Convertible Debt grew to $117.6 million in Q3 2019 per ANIP's latest filing, from $115.9 million in the prior quarter.
- Over five years, Convertible Debt peaked at $134.1 million in Q3 2018 and troughed at $112.2 million in Q1 2015.
- A 5-year average of $120.2 million and a median of $117.6 million in 2019 frame the typical range for Convertible Debt.
- The sharpest annual moves came in 2015 and 2019: Convertible Debt grew 6.46% in 2015, then declined 12.33% in 2019.
- Over 5 years, Convertible Debt stood at $113.4 million in 2015, then climbed by 6.36% to $120.6 million in 2016, then grew by 6.27% to $128.2 million in 2017, then fell by 12.28% to $112.5 million in 2018, then gained by 4.56% to $117.6 million in 2019.
- According to Business Quant data, Convertible Debt over the past three periods registered $117.6 million, $115.9 million, and $114.2 million for Q3 2019, Q2 2019, and Q1 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 117.59 Mn |
| Jun 30, 2019 | 115.86 Mn |
| Mar 31, 2019 | 114.15 Mn |
| Dec 31, 2018 | 112.46 Mn |
| Sep 30, 2018 | 134.12 Mn |
| Jun 30, 2018 | 132.13 Mn |
| Mar 31, 2018 | 130.16 Mn |
| Dec 31, 2017 | 128.21 Mn |
| Sep 30, 2017 | 126.28 Mn |
| Jun 30, 2017 | 124.38 Mn |
| Mar 31, 2017 | 122.50 Mn |
| Dec 31, 2016 | 120.64 Mn |
| Sep 30, 2016 | 118.81 Mn |
| Jun 30, 2016 | 116.99 Mn |
| Mar 31, 2016 | 115.20 Mn |
| Dec 31, 2015 | 113.43 Mn |
| Sep 30, 2015 | 115.19 Mn |
| Jun 30, 2015 | 113.67 Mn |
| Mar 31, 2015 | 112.17 Mn |
| Dec 31, 2014 | 106.54 Mn |